H2020FP7HORIZON
Slaski Uniwersytet Medyczny w Katowicach
- Country
- PLPoland
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 2,471,668
- Active
- 2009 to 2023
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EDENT1FIEuropean action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception | HORIZON | 2023 | Participant | EUR 407,656 |
| ELR-SCARA novel multi-functional elastin-like recombinant hydrogel for the prevention of scar tissue formation following a myocardial infarction: ELR-SCAR | HORIZON | 2022 | Participant | EUR 250,625 |
| INNODIA HARVESTTranslational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA | H2020 | 2020 | Participant | EUR 63,750 |
| PROFIDImplementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction | H2020 | 2020 | Participant | EUR 245,625 |
| ReGenHeartClinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study | H2020 | 2017 | Participant | EUR 591,250 |
| OcuTherEducational Network in Ocular Drug Delivery and Therapeutics | H2020 | 2016 | Partner | EUR 0 |
| INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 | H2020 | 2015 | Participant | EUR 297,450 |
| SCIENCEStem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) | H2020 | 2015 | Participant | EUR 416,000 |
| SIRENASilesian Researchers NOW! | FP7 | 2012 | Participant | EUR 10,800 |
| SIRIUSSilesian Researchers with us | FP7 | 2011 | Participant | EUR 7,278 |
| BAMIThe effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction | FP7 | 2011 | Participant | EUR 2,700 |
| SYSKIDSystems biology towards novel chronic kidney disease diagnosis and treatment | FP7 | 2010 | Participant | EUR 166,240 |
| STEPSSTrengthening Engagement in Public health research | FP7 | 2009 | Participant | EUR 12,294 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.